Showing 1 - 11 results of 11 for search 'Yanhong Deng', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
-
5
KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer by Yanhong Deng, Li Wang, Shuyun Tan, George P. Kim, Ruoxu Dou, Dianke Chen, Yue Cai, Xinhui Fu, Lei Wang, Jun Zhu, Jianping Wang
Published 2015-08-01Get full text
Article -
6
Enhanced immunotherapy response in lung adenocarcinoma patients with COPD: insights into tumor cells and immune microenvironment characteristics by Yuji Huang, Boxuan Liang, Xuewei Chen, Zhiming Li, Yanhong Deng, Jiaxin Du, Yizhou Zhong, Xi Lin, Junjun Fu, Jieyu Xie, Xin Zhang, Zhenlie Huang
Published 2025-07-01Get full text
Article -
7
Systematic Review and Meta-Analysis of Urine Neutrophil Gelatinase–Associated Lipocalin for Acute Kidney Injury in Cirrhosis by Jeremy Puthumana, Nicolas Chong Lugon, Yunshan Xu, Yanhong Deng, Pramod K. Mistry, Chirag R. Parikh, Paolo Angeli, Justin Belcher, Carmine Gambino, Mohamed Salaheldin, Sombat Treepraertsuk
Published 2024-07-01Get full text
Article -
8
Cancer tracking system improves timeliness of liver cancer care at a Veterans Hospital: A comparison of cohorts before and after implementation of an automated care coordination to... by Yapei Zhang, Catherine Mezzacappa, Lin Shen, Amanda Ivatorov, Alexandra Petukhova-Greenstein, Rajni Mehta, Maria Ciarleglio, Yanhong Deng, Woody Levin, Steve Steinhardt, Donna Connery, Michael Pineau, Ifeyinwa Onyiuke, Caroline Taylor, Michal G Rose, Tamar H Taddei
Published 2022-08-01Get full text
Article -
9
Pharmacokinetics of infigratinib and its active metabolites in Chinese patients with advanced gastric cancer harboring FGFR2 gene amplification by Jiajia Yuan, Lin Shen, Tian Shu Liu, HuiTing Xu, Jianwei Yang, Jia Wei, Haiping Jiang, Yanhong Deng, Hongming Pan, Yusheng Wang, Xiaotian Zhang, Zhi Peng, Changsong Qi, Lingli Zhang, Peiwen Hsu, Lin Song, Lei Mu, Qiao Sun, Jifang Gong, Cheng Lyu
Published 2024-12-01Get full text
Article -
10
Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRASG12C inhibitor-naïve Chinese patients with KRAS G12C-mutated metastatic colorectal cancer: a pooled analysis from phas... by Ying Yuan, Yanhong Deng, Yongdong Jin, Zengqing Guo, Yueyin Pan, Cunji Wang, Zhiwu Wang, Yi Hu, Dong Hua, Xiangjiao Meng, Zhiye Zhang, Mingfang Zhao, Xiaorong Dong, Dingzhi Huang, Xiaoyan Li, Lian Liu, Meili Sun, Huijuan Wang, Xiuwen Wang, Nong Yang, Mingjun Zhang, Sheng Hu, Dongde Wu, Jingjing Huang, Sujie Zhang, Mengna Huang, Kefeng Ding
Published 2025-07-01Get full text
Article -
11
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation by Dan-Yun Ruan, Hao-Xiang Wu, Ye Xu, Pamela N. Munster, Yanhong Deng, Gary Richardson, Dong Yan, Myung-Ah Lee, Keun-Wook Lee, Hongming Pan, Steven Hager, Xingya Li, Shaozhong Wei, Xinfang Hou, Craig Underhill, Michael Millward, Ina Nordman, Jingdong Zhang, Jianzhen Shan, Guohong Han, Jaspreet Grewal, Shirish M. Gadgeel, Rachel E. Sanborn, Seok Jae Huh, Xiaohua Hu, Yihong Zhang, Ziyong Xiang, Laisheng Luo, Xiaoxi Xie, Zhe Shi, Yaolin Wang, Ling Zhang, Feng Wang, Rui-Hua Xu
Published 2025-06-01Get full text
Article